These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 11318962

  • 1. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.
    Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB.
    Kidney Int; 2001 May; 59(5):1899-910. PubMed ID: 11318962
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis.
    Yang HC, Ma LJ, Ma J, Fogo AB.
    Kidney Int; 2006 May; 69(10):1756-64. PubMed ID: 16598202
    [Abstract] [Full Text] [Related]

  • 3. Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats.
    Ma LJ, Jha S, Ling H, Pozzi A, Ledbetter S, Fogo AB.
    Kidney Int; 2004 Jan; 65(1):106-15. PubMed ID: 14675041
    [Abstract] [Full Text] [Related]

  • 4. Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro.
    Routh RE, Johnson JH, McCarthy KJ.
    Kidney Int; 2002 Apr; 61(4):1365-76. PubMed ID: 11918743
    [Abstract] [Full Text] [Related]

  • 5. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
    Revelo MP, Federspiel C, Helderman H, Fogo AB.
    Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
    [Abstract] [Full Text] [Related]

  • 6. Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1.
    Ma LJ, Nakamura S, Whitsitt JS, Marcantoni C, Davidson JM, Fogo AB.
    Kidney Int; 2000 Dec; 58(6):2425-36. PubMed ID: 11115076
    [Abstract] [Full Text] [Related]

  • 7. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
    Memon RA, Tecott LH, Nonogaki K, Beigneux A, Moser AH, Grunfeld C, Feingold KR.
    Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature.
    Guan Y, Zhang Y, Schneider A, Davis L, Breyer RM, Breyer MD.
    Am J Physiol Renal Physiol; 2001 Dec; 281(6):F1036-46. PubMed ID: 11704554
    [Abstract] [Full Text] [Related]

  • 9. Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells.
    Nicholas SB, Kawano Y, Wakino S, Collins AR, Hsueh WA.
    Hypertension; 2001 Feb; 37(2 Pt 2):722-7. PubMed ID: 11230363
    [Abstract] [Full Text] [Related]

  • 10. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
    Kim MJ, Deplewski D, Ciletti N, Michel S, Reichert U, Rosenfield RL.
    Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
    [Abstract] [Full Text] [Related]

  • 11. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
    Park KS, Ciaraldi TP, Lindgren K, Abrams-Carter L, Mudaliar S, Nikoulina SE, Tufari SR, Veerkamp JH, Vidal-Puig A, Henry RR.
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
    [Abstract] [Full Text] [Related]

  • 12. Unique ability of troglitazone to up-regulate peroxisome proliferator-activated receptor-gamma expression in hepatocytes.
    Davies GF, McFie PJ, Khandelwal RL, Roesler WJ.
    J Pharmacol Exp Ther; 2002 Jan; 300(1):72-7. PubMed ID: 11752099
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis.
    Tsubouchi Y, Sano H, Kawahito Y, Mukai S, Yamada R, Kohno M, Inoue K, Hla T, Kondo M.
    Biochem Biophys Res Commun; 2000 Apr 13; 270(2):400-5. PubMed ID: 10753637
    [Abstract] [Full Text] [Related]

  • 14. Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.
    Kato K, Satoh H, Endo Y, Yamada D, Midorikawa S, Sato W, Mizuno K, Fujita T, Tsukamoto K, Watanabe T.
    Biochem Biophys Res Commun; 1999 May 10; 258(2):431-5. PubMed ID: 10329404
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
    Cabrero A, Cubero M, Llaverías G, Jové M, Planavila A, Alegret M, Sánchez R, Laguna JC, Carrera MV.
    Metabolism; 2003 May 10; 52(5):652-7. PubMed ID: 12759900
    [Abstract] [Full Text] [Related]

  • 16. Amelioration of anti-Thy1-glomerulonephritis by PPAR-gamma agonism without increase of endothelial progenitor cell homing.
    Westerweel PE, den Ouden K, Nguyen TQ, Goldschmeding R, Joles JA, Verhaar MC.
    Am J Physiol Renal Physiol; 2008 Feb 10; 294(2):F379-84. PubMed ID: 18077601
    [Abstract] [Full Text] [Related]

  • 17. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.
    Brown NJ, Nakamura S, Ma L, Nakamura I, Donnert E, Freeman M, Vaughan DE, Fogo AB.
    Kidney Int; 2000 Sep 10; 58(3):1219-27. PubMed ID: 10972684
    [Abstract] [Full Text] [Related]

  • 18. The effect of high glucose and PPAR-gamma agonists on PPAR-gamma expression and function in HK-2 cells.
    Panchapakesan U, Pollock CA, Chen XM.
    Am J Physiol Renal Physiol; 2004 Sep 10; 287(3):F528-34. PubMed ID: 15113752
    [Abstract] [Full Text] [Related]

  • 19. Troglitazone induces expression of PPARgamma in liver.
    Davies GF, Khandelwal RL, Roesler WJ.
    Mol Cell Biol Res Commun; 1999 Sep 10; 2(3):202-8. PubMed ID: 10662598
    [Abstract] [Full Text] [Related]

  • 20. Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells.
    Padilla J, Kaur K, Cao HJ, Smith TJ, Phipps RP.
    J Immunol; 2000 Dec 15; 165(12):6941-8. PubMed ID: 11120820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.